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The Cu(I)-catalyzed cycloaddition of terminal azides and
alkynes (click chemistry) represents a highly speciﬁc reaction
for the functionalization of biomolecules with chemical
moieties such as dyes or polymer matrices. In this study we
evaluate the use of bicinchoninic acid (BCA) as a ligand for
Cu(I) under physiological reaction conditions. We demon-
strate that the BCA–Cu(I)-complex represents an efﬁcient
catalyst for the conjugation of ﬂuorophores or biotin to
alkyne- or azide-functionalized proteins resulting in
increased or at least equal reaction yields compared to com-
monly used catalysts like Cu(I) in complex with TBTA (tris-
[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) or BPAA
(bathophenanthroline disulfonic acid). The stabilization of
Cu(I) with BCA represents a new strategy for achieving
highly efﬁcient bioconjugation reactions under physiological
conditions in many application ﬁelds.
The cycloaddition of terminal azides and alkynes represents a
highly speciﬁc conjugation reaction in organic chemistry.1 Orig-
inally this reaction required elevated temperatures and organic
solvents. It was adapted to physiological conditions (aqueous
environment, pH 7.2, 37 °C) by the introduction of Cu(I) as a
catalyst by Meldal et al.2 and Sharpless et al.3 This protocol
facilitated the efﬁcient modiﬁcation of proteins, lipids or nucleic
acids in a highly selective manner as the reaction partners, azides
and alkynes, are absent in biomolecules.4 Usually, copper is
added to the reaction as Cu(II), which is then reduced in situ to
Cu(I) by reductants, such as ascorbic acid3 or tris(2-carboxy-
ethyl)phosphine (TCEP).1 For an efﬁcient cycloaddition re-
action, Cu(I) must be present at high levels.1 However, Cu(I) is
thermodynamically unstable, it is easily oxidized to Cu(II) and/or
disproportionates to Cu(0) and Cu(II).5 In order to prevent Cu(I)
oxidation or disproportionation, it is therefore necessary to add a
suitable ligand stabilizing Cu(I) in aqueous solution under
aerobic conditions.6 The ligand must still allow enough ﬂexi-
bility for catalysis of the cycloaddition by Cu(I) to take place.
Recently, Cu(I) stabilizers such as tris[(1-benzyl-1H-1,2,3-
triazol-4-yl)methyl]amine (TBTA) or bathophenanthroline disulf-
onic acid (BPAA) have been reported to improve bioconjuga-
tions (Scheme 1).1,5 While these Cu(I) complexes have success-
fully been used in different application ﬁelds, the coupling
efﬁcacies were dependent on the kind of protein and ligand
used.7 The poor water solubility of the TBTA ligand represented
a further restriction in the reaction setup. In order to overcome
this limitation and add a new degree of freedom when optimiz-
ing click chemistry-based bioconjugation reactions, we explored
the suitability of the bicinchoninic acid (BCA)–Cu(I) complex as
a cycloaddition catalyst. The sodium salt of the 2,2′-bipyridine
derivative BCA is water-soluble and coordinates Cu(I) in a
2 : 1 stoichiometry.8 The resulting BCA–Cu(I) complex has a
strong violet color with an absorption maximum at 562 nm
(Scheme 1).9
As a model protein for the coupling reactions we used a
variant of the barnase inhibitor barstar (b*)10 in which the
N-terminal methionine had quantitatively been replaced by either
azidohomoalanine (b*[Aha]) or homopropargylglycine (b*[Hpg])
(see ESI and Fig. S1 and S2† for the production, puriﬁcation
and characterization of the proteins). In order to evaluate
whether the ligand BCA can enhance the Cu(I)-catalyzed cyclo-
addition, we reacted 1.4 μM of b*[Aha] with 20 μM of the
alkyne-functionalized ﬂuorescent dye LM155 (Scheme 1 for the
dye structure) in the presence of increasing BCA concentrations
(the other coupling reagents CuSO4, TCEP and Cu-wire were
added at standard concentrations11). After 60 min, the reaction
products were resolved on SDS-PAGE and visualized by ﬂuor-
escence imaging or Coomassie staining (Fig. 1a). In the presence
of BCA at concentrations of 0.5–8 mM, a new band (labeled **)
appeared that migrated slightly slower than the unmodiﬁed
protein (labeled *). Comparison with ﬂuorescence images
(excitation: 254 nm) revealed that this new band corresponded
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Scheme 1 Schematic representation of the cycloaddition of azides and alkynes catalyzed by BCA-chelated Cu(I). (a) Cu(I)-catalyzed azide–alkyne
cycloaddition (CuAAC) with an azide-labeled protein (grey). The 1,4-regioisomer of the triazole is preferentially formed. (b) Structure of the BCA–
Cu(I) complex. (c) Structure of the Cu(I) ligands bathophenanthroline disulfonic acid (BPAA) and tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine
(TBTA). (d) Structure of the alkyne-functionalized dye LM155 and the azide-functionalized dye LM158.
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to LM155-coupled b*. The cycloaddition between LM155 and
b* was further conﬁrmed by MALDI-TOF mass spectrometry
yielding the m/z ratio of 11 182 Da corresponding to the calcu-
lated value (11 181 Da) of the reaction product (Fig. S3†).
In order to determine optimal reaction conditions, we varied
the reaction times as well as the BCA concentrations and
quantiﬁed the coupled and uncoupled protein bands on the
Coomassie gel by densitometry analysis (Fig. 1b). At BCA con-
centrations of 4 or 8 mM and a reaction time of 60 min,
maximum conjugation yields in the range of 60% were observed.
At higher BCA concentrations (20 mM) almost no coupling was
observed. This observation is in agreement with literature data
on Cu(I)-catalyzed cycloaddition reactions indicating that a large
excess of the ligand results in slower reaction kinetics
(Fig. 1b).12
In order to compare the ligand BCA to the frequently used
ligands BPAA and TBTA, we determined the optimal
concentration of these ligands by a similar titration experiment
(Fig. S4 and S5†). For BPAA, the highest coupling efﬁcacy
(55%) was observed for 2 and 6 mM ligand at a reaction time of
60 min (Fig. S4†). In contrast, TBTA resulted only in very poor
coupling efﬁcacies, which made it impossible to perform a quan-
titative analysis (Fig. S5†). We therefore used 2 mM TBTA for
the subsequent coupling reactions as this value has consistently
been described in the literature.11
We ﬁrst directly compared the coupling efﬁcacy of b*[Aha]
with the dye LM155 catalyzed by BCA–, BPAA– and TBTA–
Cu(I) complexes under the above-determined optimized reaction
conditions. While BCA and BPAA resulted in comparable yields
of protein–dye conjugates, TBTA was the least-efﬁcient ligand
(Fig. 2a).
In order to analyze the effect of the ligands on the reverse
coupling conﬁguration (protein–alkyne, dye–azide), we per-
formed a cycloaddition reaction between b*[Hpg] and the azide-
functionalized ﬂuorescent dye LM158 (see Scheme 1 for the dye
structure). In this conﬁguration, only BCA resulted in an
efﬁcient coupling (52% yield) while both other ligands, TBTA
and BPAA, did not result in a detectable reaction product
(Fig. 2b).
We next evaluated the effect of the three Cu(I) ligands on the
coupling of azido-functionalized Thermoanaerobacter thermo-
hydrosulfuricus lipase (TTL[Aha]). Such lipases are an indust-
rially important class of enzymes as they are common in laundry
detergents and in the food industry. Their targeted modiﬁcation
therefore represents an important engineering tool in designing
efﬁcient biocatalytic processes.13
Fig. 1 Characterization of the Cu(I)-catalyzed azide–alkyne cyclo-
addition using BCA as a Cu(I) chelator. (a) Effect of BCA on the Cu(I)-
catalyzed azide–alkyne cycloaddition. b*[Aha] was subjected to Cu(I)-
catalyzed azide–alkyne cycloaddition with the alkyne-functionalized dye
LM155 in the presence of increasing BCA concentrations. After 60 min
the reaction products were resolved by SDS-PAGE and the proteins were
visualized by Coomassie staining or ﬂuorescence imaging. (*),
unlabeled b*[Aha]; (**), LM155-labeled b*[Aha]. Lane P contains
b*[Aha] protein only in the absence of LM155 and coupling reagents.
The reactions were performed in triplicate, one representative gel image
is shown. (b) Kinetics of Cu(I)-catalyzed azide–alkyne cycloaddition
between b*[Aha] and LM155 at different BCA concentrations. b*[Aha]
and LM155 were coupled as described in Fig. 1a using different reaction
times and BCA concentrations. The coupling efﬁcacy was determined
by quantifying the bands corresponding to native and LM155-functiona-
lized b*[Aha] on SDS-PAGE gels. The error bars represent the standard
deviation from three coupling reactions.
Fig. 2 Comparison of different Cu(I) chelators for the Cu(I)-catalyzed
azide–alkyne cycloaddition. Cu(I)-catalyzed azide–alkyne cycloaddition
between (a) b*[Aha] and the alkyne-functionalized dye LM155 or
(b) b*[Hpg] and the azide-functionalized dye LM158. The coupling
reaction was performed in the presence of BPAA (6 mM), TBTA
(2 mM) or BCA (4 mM) for 60 min prior to resolving the reaction pro-
ducts on SDS-PAGE. The proteins were visualized by ﬂuorescence
imaging and Coomassie staining. The coupling efﬁcacy was determined
by quantifying the bands of native (*) and dye-functionalized (**)
protein. The reactions were performed in triplicate, one representative
gel image is shown. Lane NL, no Cu(I) ligand added; lane P, unmodiﬁed
protein only without dye and coupling reagents.
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As conjugation partners for TTL[Aha] we chose alkyne-func-
tionalized biotin e.g. as an anchor for enzyme immobilization
via a streptavidin matrix, or LM155 for dye-labeling of the
enzyme. We performed the coupling reaction using the opti-
mized conditions for the three ligands (4 mM BCA; 6 mM
BPAA; 2 mM TBTA) and visualized the reaction products on
SDS-PAGE (Fig. 3). For the coupling reaction between TTL-
[Aha] and alkyne–biotin, the ligand BCA resulted in the best
coupling efﬁcacy while BPAA and TBTA resulted in close-to-
background signals only (Fig. 3a). For the conjugation of TTL-
[Aha] with LM155 similar reaction efﬁcacies were obtained for
all three ligands used (Fig. 3b). This heterogeneous coupling
efﬁcacy is in agreement with previous reports indicating that the
yield of Cu(I)-catalyzed cycloaddition reactions is profoundly
inﬂuenced by the reaction partners, by the nature of the small-
molecule ligand or whether the protein is alkyne- or azido-func-
tionalized.7,14 In agreement with literature data our results show
that the concentration and the choice of the copper ligand
strongly inﬂuence the efﬁciency of the cycloaddition
reaction.14–16
The robust performance of the BCA–Cu(I) complex under
different reaction conditions might be explained by the very
strong chelating behavior of BCA that is relatively inert to inter-
ferences with other molecules9 while still being ﬂexible enough
to expose Cu(I) for catalyzing the conjugation reaction.
Especially the superior performance of the BCA ligand in com-
parison to the rigid phenanthroline derivative BPAA supports the
ﬂexibility argument: in BCA, one pyridyl-residue may reversibly
dissociate from the Cu(I) ion providing the empty coordination
site necessary for the catalysis. Probably this coordination site is
less accessible if the BPAA ligand chelates the Cu(I) ion, thus
accounting for its inferior performance. In contrast the ﬂexible
chelating TBTA ligand provides similar performance to BCA.
However, since TBTA is a neutral molecule with little
H-bonding capacity, the BCA-complex carrying carboxylate
groups obviously is better compatible with the local environment
of some of the chosen model reactions and likely accounts for
the superior performance of the BCA–Cu(I) system.
In this study we have introduced the BCA–Cu(I) complex to
catalyze the cycloaddition between terminal azides and alkynes
in bioconjugation reactions. We have demonstrated that in the
presence of BCA signiﬁcantly improved conjugation yields were
obtained for certain combinations of a target protein and a small
molecule binding partner while in all other combinations BCA
performed at least equivalent to the previously described ligands
TBTA or BPAA. We therefore expect that the ﬁndings described
in this study will gain signiﬁcant impact in many different areas
of fundamental and applied research and development.
We thank Ingo Krossing for advice and discussion on the
Cu(I) complexes. This work was supported by the European
Research Council under the European Community’s Seventh
Framework Programme (FP7/2007-2013)/ERC Grant agreement
no. 259043-CompBioMat and the Excellence Initiative of the
German Federal and State Governments (EXC-294 and GSC-4).
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Fig. 3 Cu(I)-catalyzed azide–alkyne cycloaddition between Aha-sub-
stituted T. thermohydrosulfuricus lipase (TTL[Aha]) and (a) alkyne-func-
tionalized biotin or (b) the alkyne-containing dye LM155. The coupling
reaction was performed for 60 min in the presence of TBTA (2 mM),
BPAA (6 mM) or BCA (0.5 mM) prior to resolving the reaction products
on SDS-PAGE. Biotinylated proteins were analyzed by Western blotting.
The biotin-containing bands were detected with horseradish peroxidase-
functionalized streptavidin and subsequent chemiluminescent imaging.
LM155-coupled proteins were analyzed as described in Fig. 2. No Cu,
no copper was added to the reaction; NL, no Cu(I) ligand added; P,
unmodiﬁed protein without dye and coupling reagents.
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